ArticleSarcoma2013

Cost effectiveness of first-line treatment with doxorubicin/ifosfamide compared to trabectedin monotherapy in the management of advanced soft tissue sarcoma in Italy, Spain, and sweden.

Julian F Guest et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.